Start-Ups
MedTech Capital Matters January 2026
The best private financing deals in December across all clinical categories, and a profile of Nexus Neurotech Ventures.
Welcome to MyStrategist, the digital home for MedTech Strategist.
MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest IssueStart a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Executive Interviews
Paul Yock: A Career As A Medtech Myth Buster
Paul Yock has spent his remarkable career shattering long-held myths and confounding conventional wisdom in clinical medicine, medical education and innovation/entrepreneurship. Here he shares the highlights of this extraordinary journey with his co-founder of what is now the Stanford Mussallem Center for Biodesign, Josh Makower.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
Start-Ups
Attacking MAC, the Newest Cardiac Risk Factor
From routine CT scans, Bunkerhill Health identifies mitral annular calcification—addressing an unmet need as MAC gains recognition as an independent risk factor for heart failure, atrial fibrillation, and cardiac death, and as a driver of complications in mitral valve repair and replacement.